iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding iSpecimen Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 13 | 14 | +1 |
| Shares | 310.8K | 372.8K | +62.1K (+20.0%) |
| Value | $1.98M | $813.0K | −$1.17M (−58.9%) |
New holders (3)
Institutions that held iSpecimen Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 19,799 | $43.0K | 0.00% |
| Main Street Financial Solutions, LLC | 10,500 | $23.0K | 0.00% |
| Bank of America Corp | 1,053 | $2.00K | 0.00% |
Sold out (2)
Institutions that held iSpecimen Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Jane Street Group, LLC | 10,351 | $56.0K |
| Citigroup Inc | 1,750 | $9.00K |